Cargando…

Therapeutic targeting with DABIL‐4 depletes myeloid suppressor cells in 4T1 triple‐negative breast cancer model

In many solid tumors including triple‐negative breast cancer (TNBC), upregulation of the interleukin‐4 receptor (IL‐4R) has been shown to promote cancer cell proliferation, apoptotic resistance, metastatic potential, and a Th2 response in the tumor microenvironment (TME). Since immunosuppressive cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parveen, Sadiya, Siddharth, Sumit, Cheung, Laurene S., Kumar, Alok, Shen, Jessica, Murphy, John R., Sharma, Dipali, Bishai, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096791/ https://www.ncbi.nlm.nih.gov/pubmed/33682324 http://dx.doi.org/10.1002/1878-0261.12938

Ejemplares similares

Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
por: Wu, Qitong, et al.
Publicado: (2021)

Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants
por: Siddharth, Sumit, et al.
Publicado: (2018)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
por: Krug, Stefanie, et al.
Publicado: (2021)

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
por: Siddharth, Sumit, et al.
Publicado: (2021)

VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer
por: Song, Hongming, et al.
Publicado: (2019)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
por: Vito, Alyssa, et al.
Publicado: (2021)

ED SUM: Triple-negative breast cancer is inhibited by depleting mitochondrial copper in mice.: Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
por: Cui, Liyang, et al.
Publicado: (2020)

CD115(−) monocytic myeloid-derived suppressor cells are precursors of OLFM4(high) polymorphonuclear myeloid-derived suppressor cells
por: Zou, Yunyun, et al.
Publicado: (2023)

Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients
por: Darcy, Christabelle J, et al.
Publicado: (2014)

Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancer
por: Wu, Hongmei, et al.
Publicado: (2017)

Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas
por: Dawod, Bassel, et al.
Publicado: (2020)

SMARCA4 Depletion Induces Cisplatin Resistance by Activating YAP1-Mediated Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer
por: Kim, Jihyun, et al.
Publicado: (2021)

Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells
por: Bassey-Archibong, Blessing I, et al.
Publicado: (2017)

Depletion of Mdig Changes Proteomic Profiling in Triple Negative Breast Cancer Cells
por: Thakur, Chitra, et al.
Publicado: (2022)

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer
por: Yu, Bo, et al.
Publicado: (2021)

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer
por: Yu, Bo, et al.
Publicado: (2022)

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity
por: Kramer, Elliot D., et al.
Publicado: (2020)

An Agent-based Model for Investigating the Effect of Myeloid-Derived Suppressor Cells and its Depletion on Tumor Immune Surveillance
por: Allahverdy, Armin, et al.
Publicado: (2019)

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016)

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
por: Ramchandani, Divya, et al.
Publicado: (2021)

Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
por: Parida, Sheetal, et al.
Publicado: (2019)

Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer
por: Muniraj, Nethaji, et al.
Publicado: (2019)

Role of Omentin in Obesity Paradox in Lung Cancer
por: Parida, Sheetal, et al.
Publicado: (2021)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: Ju, YoungJun, et al.
Publicado: (2021)

Cinnamaldehyde causes apoptosis of myeloid-derived suppressor cells through the activation of TLR4
por: He, Wanzhuo, et al.
Publicado: (2019)

Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
por: Tang, Yao, et al.
Publicado: (2022)

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer
por: Nguyen, Khoa, et al.
Publicado: (2021)

On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer
por: Boudghene-Stambouli, Fadia, et al.
Publicado: (2022)

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression
por: Deng, Liufu, et al.
Publicado: (2014)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
por: Kato, Takuya, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells: Fuel the Fire
por: Achyut, B. R., et al.
Publicado: (2014)

Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1
por: Rhodes, L V, et al.
Publicado: (2015)

Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
por: Ge, Jennifer Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9j8c2s3416ien25ogism3vmh16